Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Exemestane

First Posted Date: 2009-07-03

Last Posted Date: 2010-07-20

Lead Sponsor: Pfizer

Target Recruit Count: 451

Registration Number: NCT00932165

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Phase 3

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: PF-02341066
Drug: Pemetrexed
Drug: Docetaxel

First Posted Date: 2009-07-03

Last Posted Date: 2017-01-02

Lead Sponsor: Pfizer

Target Recruit Count: 347

Registration Number: NCT00932893

Locations: 🇺🇸
University of Arkansas for Medical Research, Winthrop Rockefeller Cancer Institute, Little Rock, Arkansas, United States
🇺🇸
Comprehensive Blood and Cancer Center, Bakersfield, California, United States
🇺🇸
Tower Cancer Research Foundation, Beverly Hills, California, United States

and more 241 locations

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

Phase 1

Completed

Conditions: Alzheimer's Disease
Huntington's Disease

Interventions: Drug: Dimebon + Omeprazole
Drug: Dimebon alone
Drug: Dimebon + Ketoconazole

First Posted Date: 2009-07-02

Last Posted Date: 2009-11-18

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT00931073

Locations: 🇺🇸
Pfizer Investigational Site, Kalamazoo, Michigan, United States

A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients

Completed

Conditions: Dermatitis, Contact

Interventions: Drug: Tablet Methylprednisolone (4 or 16 mg)

First Posted Date: 2009-06-30

Last Posted Date: 2019-01-02

Lead Sponsor: Pfizer

Target Recruit Count: 80

Registration Number: NCT00929981

Locations: 🇮🇳
Pfizer Investigational Site, Ludhiana, Punjab, India

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo
Drug: PF-04447943

First Posted Date: 2009-06-30

Last Posted Date: 2020-11-19

Lead Sponsor: Pfizer

Target Recruit Count: 191

Registration Number: NCT00930059

Locations: 🇺🇸
Neurology Clinic, PC, Cordova, Tennessee, United States
🇺🇸
ATP Clinical Research, Inc., Costa Mesa, California, United States
🇺🇸
Southwestern Research Incorporated, Glendale, California, United States

and more 39 locations

A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population

Completed

Conditions: Hypertension

Interventions: Drug: quinapril

First Posted Date: 2009-06-30

Last Posted Date: 2011-05-04

Lead Sponsor: Pfizer

Target Recruit Count: 329

Registration Number: NCT00930722

Locations: 🇮🇳
Pfizer Investigational Site, Kolkata, West Bengal, India

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: DMARDs or Biologics

First Posted Date: 2009-06-29

Last Posted Date: 2011-08-10

Lead Sponsor: Pfizer

Target Recruit Count: 156

Registration Number: NCT00929357

A Global Active Surveillance for Community Acquired Pneumonia

Not Applicable

Completed

Conditions: Community Acquired Pneumonia

Interventions: Procedure: Blood draw
Procedure: Chest X-ray
Procedure: urine specimen
Procedure: Nasopharyngeal swab
Procedure: sputum

First Posted Date: 2009-06-29

Last Posted Date: 2012-04-13

Lead Sponsor: Pfizer

Target Recruit Count: 5172

Registration Number: NCT00929721

Locations: 🇵🇱
Pfizer Investigational Site, Chrzanow, Poland

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

Phase 1

Completed

Conditions: Colitis, Ulcerative

Interventions: Biological: Single dose-group A
Biological: Multiple dose- Group B
Biological: Multiple dose-Group B

First Posted Date: 2009-06-26

Last Posted Date: 2009-06-26

Lead Sponsor: Pfizer

Target Recruit Count: 80

Registration Number: NCT00928681

Locations: 🇪🇸
Pfizer Investigational Site, Madrid, Spain

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Phase 4

Completed

Conditions: Overactive Bladder

Interventions: Drug: Fesoterodine
Drug: Placebo

First Posted Date: 2009-06-25

Last Posted Date: 2013-01-17

Lead Sponsor: Pfizer

Target Recruit Count: 566

Registration Number: NCT00928070

Locations: 🇺🇸
Pfizer Investigational Site, Spokane, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy